Episode Details

67% of beauty startups fail in their first year — not from bad branding, but from signing the wrong manufacturing contract before they understood what they were agreeing to. In this episode, we unpack why first-time skincare founders keep falling into the same three traps, and what a development-partner relationship looks like when it's structured around founder outcomes instead of order volume.

 This is essential listening for anyone preparing to launch a skincare or cosmetics brand in the United States, European Union, or Canadian markets — whether you're an independent founder, a brand consultant, or an executive launching a new line under an existing parent company.

In this episode: 

• Why "low MOQ" is rarely the binding constraint — and what actually is 
• The differentiation illusion: how 30 brands end up selling the same base formula under different labels 
• MoCRA, FDA registration, and the regulatory blind spots that surface only at the border 
• The structural difference between a contract manufacturer and a development partner 
• 
  
• What Glossier and Tower 28 actually did before launch — and why it wasn't luck 
• The 12 questions every founder should ask before signing anything 
• Why the indie beauty market is growing 22.3% YoY against 6.1% for conglomerates

Most of the people advising first-time founders make money when you move fast and order big. That's not a conspiracy — it's just how the economics work. The reliable counter is working with someone whose model is built around your success, not your order volume. 

Hosted by Diego Lapetina, PharmD, MSc, PhD — Co-founder and Creative Director at Atomic Pom Labs, a sensory branding and cosmetic innovation consultancy serving first-time skincare founders across the US, EU, Canada, and Brazil.

Download the full white paper companion to this episode at atomicpomlabs.com. 

#SkincareBrand #BeautyFounder #CosmeticManufacturing #MoCRA #IndieBeauty

Two Geeks at a Bench